Analysis reveals poor outcomes in refractory DLBCLAugust 12, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Insured cancer patients report ‘overwhelming’ financial distressAugust 11, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Advanced cancer patients have lower survival after cardiac arrestAugust 9, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Database may provide insight into childhood cancersAugust 9, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatrics
Delirium linked to early death in advanced cancer patientsAugust 2, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHematology NursingRelated Issues
FDA grants acalabrutinib breakthrough designationAugust 2, 2017Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive Lymphomas
Understanding childhood cancer in sub-Saharan AfricaAugust 1, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatrics
ASCO updates guidelines on antiemetic use in cancer patientsAugust 1, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHematology NursingPediatricsPharmacyRelated Issues
Developing better mouse modelsJuly 28, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Health Canada approves new use for brentuximab vedotinJuly 26, 2017Lymphoma & Plasma Cell DisordersPharmacyHodgkin LymphomaAggressive Lymphomas
High ORR with sequential regimen in CLLJuly 25, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
CHMP recommends new indication for obinutuzumabJuly 22, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Modified, CB-derived NK cells target CLL and BLJuly 21, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
AYA cancer survivors struggle with social functioningJuly 21, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPediatricsRelated Issues
CAR T-cell therapy ‘highly effective’ in high-risk CLLJuly 19, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAggressive Lymphomas
